Peritoneal fibrosis (PF) is one of the most serious sion in human peritoneal mesothelial cells.
complications after long-term continuous ambulatory
Background. Peritoneal matrix accumulation is characterisperitoneal dialysis (CAPD) [1] . In vitro and in vivo studies tic of peritoneal fibrosis (PF). Continuous ambulatory peritohave shown that proliferation of human peritoneal mesoneal dialysis (CAPD) patients who had persistent transforming thelial cells (HPMCs) accompanied by matrix expansion growth factor-␤ (TGF-␤) in their drained effluent had an increased risk of PF. We previously reported that TGF-␤ stimuis important in the pathogenic process of PF [2] . Translates the expression of types I and III collagen mRNA in cultured forming growth factor-␤ (TGF-␤) increases matrix accu- also had an increased risk of PF [3] . In addition, we kinase (ERK1/2, p44/p42) pathways have been shown to particpreviously reported that TGF-␤ stimulates expression of ipate in TGF-␤ signaling. Our current study identified these types I and III collagen mRNA in cultured HPMCs [4] . Results. is translocated to the nucleus to regulate transcription
In contrast, the same concentration of dipyridamole had no of target genes. In a study of human mesangial cells, effect on TGF-␤-induced activation of Smad2.
Poncelet, de Caestecker and Schnaper demonstrated
Conclusion. Dipyridamole inhibits TGF-␤-induced collagen gene expression in HPMC through modulation of the ERK that SMAD proteins are activated by TGF-␤1 and then pathway. Our study of dipyridamole may provide therapeutic participate in TGF-␤1-stimulated type I collagen expresbasis for clinical applications in the prevention of PF.
sion [6] . In addition to the SMAD proteins, the mitogenactivated protein kinase (MAPK) pathways have been proposed to function downstream of the TGF-␤ signaling that ERK are activated by TGF-␤, and the blockade of for cAMP were obtained from Cayman Chemical (Ann Arbor, MI, USA). Selective cAMP-dependent protein kithe ERK pathway results in inhibition of TGF-␤-induced type I collagen gene expression [8] . These renase (PKA) inhibitor H-89 was obtained from Calbiochem (La Jolla, CA, USA). BCA reagents were from Pierce ports suggest that both the SMAD and ERK pathways may be involved in TGF-␤-induced collagen synthesis (Rockford, IL, USA). Phosphorylated and nonphosphorylated polyclonal antibodies to ERK1/2, Smad2, and Smad4 and fibrogenesis. However, there are, to our knowledge, no data available regarding the presence and activation were all purchased from Biolabs (New England, MA, USA). Human collagen ␣1 (I) cDNA was purchased from of these intracellular signals of TGF-␤ in HPMCs.
Dipyridamole [2,6-bis(diethanolamino)-4,8-dipiperiAmerican Type Culture Collection (Rockville, MD, USA). Agents used to isolate the total RNA and Northern blot dinopyrimido-(5,4-d)-yrimidine] is a widely used antiplatelet agent and acts as an phosphodiesterase inhibitor analysis were obtained from Boehringer Mannheim (Mannheim, Germany) unless otherwise specified. Dithat increases intracellular cAMP [9] . In addition to its antiplatelet effect, we previously demonstrated that dipyridamole used in this study was a generous gift from Boehringer Ingelheim. All other chemicals used were of pyridamole in rat mesangial cells may exert an antifibrogenic effect by reducing the expression of type I collagen analytical grade. mRNA [10] . It has been shown in rat aortic smooth Establishment of HPMC culture muscle cells (SMC) [11] and mesangial cells [12] that raising intracellular cAMP inhibits activation of ERK.
Specimens of human omentum were obtained from abdominal surgical procedures for elective gastric cancer Our previous reports of HPMC using agents that increased intracellular cAMP also demonstrated a reduced resection and the omentum was grossly normal. HPMC culture was carried out as in our previous reports [4, 13] . expression of collagen ␣1(I) mRNA [4, 13] . These data support our hypothesis that dipyridamole may attenuate Briefly, the surgically removed human omentum was washed three times with phosphate-buffered saline (PBS) TGF-␤-induced collagen synthesis in HPMCs. We speculated that, by increasing intracellular cAMP, dipyriand then digested with trypsin EDTA (0.125%; GIBCO) for 15 minutes. After centrifugation, the cell pellet was damole has an inhibitory effect on TGF-␤-induced activation of SMAD proteins and/or the ERK pathways. washed with culture medium and then seeded into a gelatin-coated (1 mg/mL) flask. The medium was changed on We report here an antifibrogenic effect of dipyridamole on TGF-␤-treated HPMCs. The intracellular downthe third day. RPMI-1640 medium containing 20% FCS, penicillin (100 U/mL), streptomycin (100 g/mL), and stream factors, including SMAD proteins and ERK pathways, are explored in TGF-␤-stimulated HPMCs. The insulin (30 g/mL) was used. After two to four days, the cells became confluent and were subcultured with regulatory effects of dipyridamole on these intracellular signals of HPMCs and the resulting inhibition of collagen medium containing 10% FCS. HPMCs were identified by the presence of vimentin and cytokeratin, but without gene expression also were investigated. Our results may provide a pharmacological basis for using dipyridamole desmin and factor VIII-related antigen by the immunofluorescence method. All experiments were performed in the treatment of PF.
in passage 1 to 3 cells.
METHODS

Northern blot analysis Materials
To determine the effect of dipyridamole on collagen gene expression, HPMCs were grown in RPMI suppleFetal calf serum (FCS) was obtained from Biochrome KG (Berlin, Germany). Culture flasks and plates were mented with 10% FCS until subconfluency. HPMCs were arrested by 0.5% FCS for 24 hours and were then treated purchased from Corning (Corning, NY, USA) and precoated with 1.6 g/cm 2 of Vitrogen 100 (Celtrix Lab, with TGF-␤ (2.5 ng/mL) in the absence or presence of various concentrations of dipyridamole. After 24 hours, Palo Alto, CA, USA) before cell loading. Trypsin-ethylenediaminetetraacetic acid (EDTA), RPMI-1640 mecells were harvested for isolation of total RNA, as previously described [4, 13] . The concentration of each samdium, glutamine, and trypan blue were obtained from GIBCO (Grand Island, NY, USA). Aprotinin, adenople was determined using spectrophotometry with the absorbance at 260 nm (A 260 ). The purity of each sample sine 5Ј-triphosphate (ATP), leupeptin, phenylmethylsulfonyl fluoride (PMSF), sodium orthovanadate (Na 3 VO 4 ), was determined based on the ratio of A 260 to A 280 . Ten micrograms of RNA were electrophoresed on a 1% agabovine serum albumin (BSA), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), dibutyrylrose gel containing 1 mol/L formaldehyde in MOPS buffer (0.2 mol/L morpholinopropanesulfonic acid, 0.05 cAMP (DBcAMP), 3-isobutyl-1-methylxanthine (IBMX), and other tissue culture reagents were purchased from mol/L Na acetate, 0.01 mol/L EDTA). Equivalency of sample loading and lack of degradation was verified by Sigma (St. Louis, MO, USA). TGF-␤1 was obtained from R&D Laboratory. The enzyme immunoassay (EIA) kits ethidium bromide staining of 28S and 18S rRNA bands.
Then RNA was transferred to nylon membranes by overStatistical analysis night capillary action followed by fixation in an ultravio-
The results are expressed as mean Ϯ SEM, unless let cross-linker. otherwise stated. These statistical analyses were carried For Northern blotting, a 1.5 kb EcoRI fragment of out using StatView IV on a personal computer. Statistical collagen ␣1(I) and a 0.7 kb HindIII/EcoRI fragment significance (P Ͻ 0.05) was evaluated using the Student of collagen ␣1(III) were subcloned, respectively, into t test or one-way analysis of variance with modified t test pBSII/SK (Stratagene, La Jolla, CA, USA) and used as performed using the Bonferroni correction. templates for in vitro transcription of antisense digoxigenin-conjugated riboprobes according to the manufac-RESULTS turer's instructions (Boehringer Mannheim). The blots Dipyridamole inhibits TGF-␤-induced ␣1(I) and were developed using CSPD (Boehringer Mannheim) as ␣1(III) mRNA expression in HPMCs the substrate for alkaline phosphatase, as described by the supplier. The signal intensity recorded on x-ray film
The effects of TGF-␤ and dipyridamole on the expreswas then quantified with computerized densitometry and sion of collagen ␣1(I) and ␣1(III) mRNA level were was normalized against the signal of glyceraldehyde-3-analyzed in HPMC. Similar to our previous report [4] , phosphate dehydrogenase (GAPDH) messages. Dipyridamole had been reported to exert its biological mmol/L EDTA, 2 mmol/L EGTA, 40 mmol/L ␤-glyceroeffect through the cAMP-PKA pathway [9] . Accordingly, phosphate, 50 mmol/L NaF, 10 mmol/L sodium pyrowe examined effect of DBcAMP on TGF-␤-induced colphosphate, 200 mol/L sodium orthovanadate, 10 g leulagen ␣1(I) and ␣1(III) mRNA expression, and tested peptin/mL, 200 units of aprotinin/mL, 1 mol/L pepstatin whether the blockade of cAMP-PKA pathway could over-A, 1 mmol/L PMSF, 100 mmol/L okadaic acid). The cell come the inhibitory effect of dipyridamole in TGF-␤-lysate was centrifugated at 14,000 rpm for 10 minutes, treated HPMC. As expected, the addition of DBcAMP and the protein concentration of the supernatant was (1 mmol/L), a membrane-permeable analogue of cAMP, measured by BCA protein assay (Pierce).
decreased the expression of collagen ␣1(I) and ␣1(III) mRNA expression. Moreover, in the presence of H-89, Western blot analysis a nonspecific PKA inhibitor, the inhibitory effects of Western blotting analyses of ERK1/2 and Smad2 phosdipyridamole on collagen ␣1(I) and ␣1(III) mRNA exphorylation were performed according to the manufacpression were almost completely reversed. turer's protocol using phospho-specific antibodies. Briefly, SMAD proteins are present in HPMC and the Smad2 HPMCs were low serum (0.5% FCS) starved for 24 hours is activated by TGF-␤ and then stimulated with TGF-␤ (2.5 ng/mL) for different lengths of time. To evaluate the inhibitory effect of To investigate the molecular mechanisms involved in dipyridamole on TGF-␤-stimulated activation of ERK TGF-␤-induced collagen gene expression in HPMCs, we and/or SMAD pathways, HPMC was incubated with 17 first examined whether HPMCs express SMAD proteins g/mL dipyridamole for 30 minutes before stimulation and then determined their modulations by TGF-␤ (Fig. with TGF-␤. Cells were harvested at the indicated time 2). Protein levels of Smad2 (58 kD) were detected in period for Western blotting. In addition, lanes of cells quiescent (control) HPMC; they slightly increased from were treated with 3 or 10 mol/L H89 for 30 minutes 15 minutes to 4 hours, and then decreased by 16 hours before dipyridamole. Cell lysates (20 g protein) were of incubation with TGF-␤ ( Fig. 2A) . Protein levels of separated by SDS-PAGE (12%) and then transferred to Smad4 (62 kD) did not change in response to TGF-␤. PVDF membrane (Millipore, Bedford, MA, USA). For These data are similar to those observed in other cells, immunodetection, membranes were probed with primary demonstrating that SMAD proteins are also present in antibody followed by incubation with peroxidase-conjuHPMCs. gated secondary antibodies. Bands were visualized by To investigate whether TGF-␤ activates Smad2 in the enhanced chemiluminescence (ECL) system (Amer-HPMC, lysates were electrophoresed through two parallel polyacrylamide gels, followed by Western blotting. sham). As shown in Figure 2B , TGF-␤ (2.5 ng/mL) induced a Activation of the ERK pathway by TGF-␤ in HPMCs rapid phosphorylation of Smad2 that began within 15 In previous (unpublished) studies we found that ERK1 minutes, peaked at 15 to 30 minutes, and then returned and ERK2 were present in primary culture of HPMC to baseline values by 8 hours. Results are expressed as the and were activated after treatment with platelet-derived ratio between phosphorylated and nonphosphorylated growth factor (PDGF; 20 ng/mL). We also found that this PDGF-induced ERK1/2 activation could be completely Smad2. inhibited by preincubation with PD98059, a specific inpected, pretreatment of HPMCs with PD98059 prehibitor of MEK. Our current study evaluated whether vented the TGF-␤-stimulated ERK1/2 activation (Fig. TGF-␤ also activates ERK1/2 in HPMC. As shown in 5). Both dipyridamole and DBcAMP abrogated this re- Figure 3 , ERK1/2 pathways were activated beginning sponse in a dose-dependent manner. At a concentration within 15 minutes after TGF-␤ was added, peaked at 30 that inhibited collagen gene expression (6 to 17 g/mL; minutes, and persisted for approximately four hours. To Fig. 1 ), dipyridamole suppressed the ERK1/2 activation examine whether this activation of the ERK pathway by TGF-␤. In contrast, the same concentration of dipyricontributed to TGF-␤-induced collagen gene expression, damole had no effect on TGF-␤-induced activation of we evaluated the effect of PD98059 on collagen gene Smad2 (Fig. 6 ). This implied that the inhibitory effect expression induced by TGF-␤. HPMCs were pretreated of dipyridamole on TGF-␤-induced collagen gene exwith various concentrations of PD98059 for one hour and pression in HPMC mainly occurs through modulations then incubated with TGF-␤ (2.5 ng/mL) for 24 hours of the ERK pathway. (Fig. 4) . As shown, PD98059 suppressed the TGF-␤-induced ␣1(I) mRNA expression in a dose-dependent Interaction of the ERK pathway and the SMAD manner (Fig. 4) . These data indicate that the ERK pathpathway in HPMCs way is involved in TGF-␤-mediated collagen gene tranIt has been postulated that the activation of Smad2 scription.
by hepatocyte growth factor is downstream of MEK [14] . Although the nature of this interaction is not clear, we Dipyridamole inhibits activation of ERK1/2, but not performed experiments to evaluate the potential interacSmad2, by TGF-␤ tion between these two pathways. HPMC pretreated To analyze the mechanisms and effect of dipyridamole with PD98059 did not influence the activation of Smad2 on TGF-␤-mediated collagen gene induction further, the on TGF-␤ treatment (Fig. 7) . These observations suggest effects of dipyridamole on signaling transduction paththat in HPMC, the TGF-␤ signal activates two indepenways downstream to TGF-␤ were examined. As shown, dent pathways: the ERK pathway and the SMAD pathway. TGF-␤ induced the activation of ERK1/2, and as ex- 
DISCUSSION
between TGF-␤ and type I collagen gene expression remains unknown, we evaluated whether the downstream We [4] and others [3] have shown that, by inducing signaling factors of TGF-␤, SMAD proteins and/or the the expression of collagen ␣1(I) and collagen ␣1(III) ERK pathway, are modulated by dipyridamole. To our mRNA in HPMCs, TGF-␤ may be associated with an knowledge this is the first report investigating the endogincreased risk of PF. Our current study demonstrates that enous SMAD pathway in the primary culture of HPMCs. dipyridamole inhibits the TGF-␤-induced expression of Our study shows that Smad2 and Smad4 are present in collagen ␣1(I) mRNA mainly through a cAMP-dependent mechanism (Fig. 1) . Because the molecular link HPMC (Fig. 2) . In response to TGF-␤, Smad2 is acti- vated (phosphorylated) in a time-dependent manner. ␤-induced ␣1(I) collagen mRNA expression (Fig. 1) , an These findings indicate that SMAD proteins participate effect that cannot be fully explained by the complete in TGF-␤-induced collagen synthesis and the developblockade of the ERK pathway by PD98059 (Fig. 5) . ment of PF.
These data implied that dipyridamole inhibited the TGFPrevious experiments suggest that the Smad2 protein ␤-induced ␣1(I) collagen mRNA expression through anplays a pivotal role in the TGF-␤ signaling pathway [5] [6] [7] .
other as yet unidentified pathway. A recent study in However, our data showed that dipyridamole had no NRK fibroblasts demonstrated that one protein, called effect on TGF-␤-induced Smad2 activation (Fig. 6 ). In connective tissue growth factor (CTGF), acts as a downcontrast, dipyridamole inhibited TGF-␤-induced activastream mediator of TGF-␤-induced collagen synthesis tion of the ERK pathway (Fig. 5) . To verify this, similar and can be down-regulated by elevated intracellular experiments were carried out using DBcAMP, which cAMP [16] . The identification of CTGF in TGF-␤-inhibited TGF-␤-induced activation of the ERK pathway treated HPMC and their possible modulation by dipyriin a dose-dependent manner (Fig. 5) . By using the trypandamole deserves further study. blue exclusion method and measuring lactate dehydrogeGiven the involvement of the SMAD pathway and nase (LDH) activity of the supernatant as previously the ERK pathway in TGF-␤ signaling of HPMC, it is described [4, 13] , we found that dipyridamole at a conintriguing to speculate that potential cross-talk exists centration of 17 g/mL or lower did not result in cytotoxbetween these two pathways. However, in our current icity of HPMC (data not shown). Therefore, the inhibistudy, PD98059 failed to prevent TGF-␤-induced Smad2 tory effects of higher concentrations of dipyridamole on activation in HPMC, and this activation of the Smad2 by TGF-␤-induced activation of SMAD proteins were not TGF-␤ was independent of the ERK signaling pathway. examined. These data imply that the inhibitory effect of These data suggest that in TGF-␤-treated HPMC, the dipyridamole on TGF-␤ inducibility of collagen ␣1(I) SMAD pathway could be a distinct, parallel pathway gene expression mainly operate through modulations of from the ERK signaling pathway. Further investigation the ERK pathway rather than of the SMAD proteins. of these two downstream pathways of TGF-␤ and their The concept that the ERK pathway may serve as a possible interactions may elucidate the pleiotropic efdownstream signaling factor for TGF-␤ and play a role fects of TGF-␤ in HPMCs. in fibrogenesis is relatively new [15] . Our preliminary In summary, in HPMCs both the ERK and SMAD unpublished finding that dipyridamole and DBcAMP pathways are involved in the response to TGF-␤. The inhibited PDGF-stimulated ERK1/2 activation in HPMC inhibitory effect of dipyridamole on TGF-␤-induced colled to our current study, which demonstrates that the lagen ␣1 (I) gene expression may function mainly through ERK pathway in HPMC also is activated by TGF-␤ modulating the ERK pathway. (Fig. 3) . In addition, the blockade of ERK by PD98059 attenuated, but did not completely inhibit, the increase ACKNOWLEDGMENTS in ␣1(I) collagen mRNA expression induced by TGF-␤ (Fig. 4) . These data suggest that the ERK pathway plays 
